Nilotinib Capsule
Product Images NDC 13668-711

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Nilotinib (NDC 13668-711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150mg (150mg)

Packaging label for Nilotinib Capsules 150 mg by Torrent Pharmaceuticals Limited. The label shows the product name, strength, and dosage form as oral capsules. It includes pharmacist instructions to dispense a Medication Guide, dosage storage information, and contents of 4 individual blister packs containing 28 capsules each. The label also notes the product is prescription only and child-resistant packaging is used.*

FDA Label Image

200mg (200mg)

The image shows a flat carton packaging for Nilotinib Capsules 200 mg by Torrent Pharmaceuticals Limited. Each box contains 4 individual blister packs with 28 capsules each. The label includes pharmacist instructions to dispense a Medication Guide, storage guidelines, and dosage advice to take capsules on an empty stomach with specific timing around food intake.*

FDA Label Image

Image (7aa7b567 B0a4 460e 9575 0d8ff5dbd537 01)

Chemical structure of nilotinib, shown with its molecular framework and associated groups, including a trifluoromethyl group and a heterocyclic ring system.*

FDA Label Image

Image (7aa7b567 B0a4 460e 9575 0d8ff5dbd537 02)

A survival curve chart illustrating treatment-free survival percentage over time in weeks since targeted therapy initiation. The graph includes a central survival curve with dashed lines indicating confidence intervals, markers for censored observations, and a timeline with numbers at risk, events, and censored data points. The x-axis measures time in weeks (up to 144 weeks), and the y-axis shows treatment-free survival percentage from 0 to 100%.*

FDA Label Image

Image (7aa7b567 B0a4 460e 9575 0d8ff5dbd537 03)

Survival curve chart depicting treatment-free survival percentage over time since first-line treatment in weeks. The chart includes a solid survival curve with upper and lower 95% confidence intervals indicated by dotted lines, as well as markings for censored observations. The x-axis shows time in weeks, and the y-axis shows treatment-free survival percentage from 0 to 100%. Additional data on patients at risk, events, and censored numbers is displayed below the graph.*

FDA Label Image

Image (7aa7b567 B0a4 460e 9575 0d8ff5dbd537 04)

FDA Label Image

Image (7aa7b567 B0a4 460e 9575 0d8ff5dbd537 05)

Packaging label for Nilotinib Capsules 150 mg oral capsules by Torrent Pharmaceuticals Limited. The carton contains 28 capsules with instructions for pharmacist and storage. The label includes dosage warnings, instructions for use, and manufacturer information.*

FDA Label Image

Image (7aa7b567 B0a4 460e 9575 0d8ff5dbd537 06)

The packaging label for Nilotinib Capsules 200 mg by Torrent Pharmaceuticals Limited features a white and olive green design. The carton contains 28 capsules, with instructions for pharmacists to dispense the accompanying Medication Guide. Storage and usage information are provided along with manufacturer and distributor details. The label includes warnings to take capsules on an empty stomach and storage conditions.*

FDA Label Image

Image (7aa7b567 B0a4 460e 9575 0d8ff5dbd537 184 2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.